Surgery Partners, Inc. (FRA:1SP)

Surgery Partners Statistics

Total Valuation

FRA:1SP has a market cap or net worth of EUR 1.89 billion. The enterprise value is 6.63 billion.

Market Cap	1.89B
Enterprise Value	6.63B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	128.45M
Shares Outstanding	n/a
Shares Change (YoY)	+0.59%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	1.42%
Owned by Institutions (%)	64.25%
Float	55.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	25.95
PS Ratio	0.67
PB Ratio	0.62
P/TBV Ratio	n/a
P/FCF Ratio	11.42
P/OCF Ratio	7.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.87, with an EV/FCF ratio of 40.05.

EV / Earnings	-45.35
EV / Sales	2.34
EV / EBITDA	9.87
EV / EBIT	14.20
EV / FCF	40.05

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 1.09.

Current Ratio	1.88
Quick Ratio	1.34
Debt / Equity	1.09
Debt / EBITDA	5.13
Debt / FCF	20.02
Interest Coverage	1.76

Financial Efficiency

Return on equity (ROE) is 0.66% and return on invested capital (ROIC) is 4.47%.

Return on Equity (ROE)	0.66%
Return on Assets (ROA)	4.19%
Return on Invested Capital (ROIC)	4.47%
Return on Capital Employed (ROCE)	7.05%
Revenue Per Employee	186,830
Profits Per Employee	-9,739
Employee Count	15,000
Asset Turnover	0.42
Inventory Turnover	28.71

Taxes

In the past 12 months, FRA:1SP has paid 106.71 million in taxes.

Income Tax	106.71M
Effective Tax Rate	84.31%

Stock Price Statistics

The stock price has decreased by -34.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.55%
50-Day Moving Average	16.95
200-Day Moving Average	19.11
Relative Strength Index (RSI)	39.55
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.47

Income Statement

In the last 12 months, FRA:1SP had revenue of EUR 2.80 billion and -146.08 million in losses. Loss per share was -1.16.

Revenue	2.80B
Gross Profit	670.25M
Operating Income	442.34M
Pretax Income	126.57M
Net Income	-146.08M
EBITDA	570.19M
EBIT	442.34M
Loss Per Share	-1.16

Balance Sheet

The company has 173.36 million in cash and 3.31 billion in debt, giving a net cash position of -3.14 billion.

Cash & Cash Equivalents	173.36M
Total Debt	3.31B
Net Cash	-3.14B
Net Cash Per Share	n/a
Equity (Book Value)	3.03B
Book Value Per Share	11.50
Working Capital	439.96M

Cash Flow

In the last 12 months, operating cash flow was 240.60 million and capital expenditures -75.17 million, giving a free cash flow of 165.43 million.

Operating Cash Flow	240.60M
Capital Expenditures	-75.17M
Free Cash Flow	165.43M
FCF Per Share	n/a

Margins

Gross margin is 23.92%, with operating and profit margins of 15.78% and -5.21%.

Gross Margin	23.92%
Operating Margin	15.78%
Pretax Margin	4.52%
Profit Margin	-5.21%
EBITDA Margin	20.35%
EBIT Margin	15.78%
FCF Margin	5.90%

Dividends & Yields

FRA:1SP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.59%
Shareholder Yield	-0.59%
Earnings Yield	-7.73%
FCF Yield	8.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:1SP has an Altman Z-Score of 0.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.98
Piotroski F-Score	6